# US 2025/0084373 A1 · Method of producing retinal tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084373 A1
- Document ID: US20250084373A1
- Status: Published application
- Kind: A1
- Application number: 18/580,081
- Filed: 2022-07-20
- Published: 2025-03-13
- Earliest claimed: 2021-07-21
- Assignees: Kyoto University
- Applicants: Kyoto University
- Inventors: Mototsugu EIRAKU
- Web page: https://patentgrep.com/patent/US20250084373A1

## CPC

- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C12N 5/0621: {Eye cells, e.g. cornea, iris pigmented cells (photoreceptors C12N5/062)}
- A61K 35/30: Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
- A61L 27/3804: {characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells}
- A61L 27/3834: {Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells}
- A61L 27/3895: {using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions}
- A61P 27/02: Ophthalmic agents
- C07K 14/51: Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
- C12M 3/00: Tissue, human, animal or plant cell, or virus culture apparatus
- C12M 21/08: {for producing artificial tissue or for ex-vivo cultivation of tissue (prostheses A61F2/00, grafts A61L27/00)}
- C12M 23/20: {Material Coatings (immunocoatings C12M25/00)}
- C12M 25/06: {Plates; Walls; Drawers; Multilayer plates}
- C12N 5/06: {Animal cells or tissues; Human cells or tissues (preservation of excised living parts A01N1/10)}
- C12N 5/10: Cells modified by introduction of foreign genetic material
- A61L 2430/16: for reconstruction of eye parts, e.g. intraocular lens, cornea
- C12N 2501/155: Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
- C12N 2501/2302: Interleukin-2 (IL-2)
- C12N 2503/02: Drug screening
- C12N 2506/02: from embryonic cells
- C12N 2506/45: from artificially induced pluripotent stem cells
- C12N 2533/30: Synthetic polymers
- C12N 2533/52: Fibronectin; Laminin
- C12N 2535/10: Patterned coating
- C12N 2539/10: Coating allowing for selective detachment of cells, e.g. thermoreactive coating
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}

## Abstract

The present disclosure includes a method of producing a retinal tissue, the method including inducing differentiation of pluripotent stem cells into a retinal tissue on a surface of a culture substrate.

## Claims

### Claim 1

A method of producing a retinal tissue, comprising
inducing differentiation of pluripotent stem cells into a retinal tissue on a surface of a culture substrate,
wherein the culture substrate comprises a region A and a region B on the surface,
the differentiation is induced is the region A,
the region A has cell adhesiveness, and
the region B is adjacent to at least a part of the region A and has cell adhesiveness lower than the cell adhesiveness of the region A.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the region A is coated with a cell-adhesive material.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the cell-adhesive material is laminin.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the region A is surrounded by the region B.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the region B is coated with a non-cell-adhesive material.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the non-cell-adhesive material is an MPC polymer.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the inducing differentiation of pluripotent stem cells into a retinal tissue comprises the following steps:
(1) culturing pluripotent stem cells in a medium containing a BMP signaling inhibitor; and
(2) culturing the cells obtained by the step (1) in a medium containing a BMP signaling activator.

### Claim 8 (depends on 7)

The method according to claim 7, wherein the BMP signaling activator is BMP4.

### Claim 9 (depends on 7)

The method according to claim 7, wherein the BMP signaling inhibitor is LDN-193189.

### Claim 10

A method of producing a retinal tissue, comprising the following steps:
(1) culturing pluripotent stem cells in a medium containing a BMP signaling inhibitor; and
(2) culturing the cells obtained by the step (1) in a medium containing a BMP signaling activator.

### Claim 11 (depends on 1)

A retinal tissue produced by the method according to claim 1.

### Claim 12

A sheet-like pluripotent stem cell-derived retinal tissue having a circular shape with a diameter of 1 to 10 cm.

### Claim 13 (depends on 11)

A composition comprising the retinal tissue according to claim 11.

### Claim 14 (depends on 13)

The composition according to claim 13, wherein the composition is for use in the treatment of a disease.

### Claim 15 (depends on 14)

The composition according to claim 14, wherein the disease is retinitis pigmentosa.

### Claim 16 (depends on 13)

The composition according to claim 13, wherein the composition is for use in evaluating toxicity or efficacy of an agent.
